METACYTE
DEAD

Serial Number

85218796

Owner

Metacyte Business Lab LLC

Attorney

Jennifer L. Kovalcik

Filing Date

Jan 16, 2011

Add to watchlist:

No watchlists yet
View on USPTO

METACYTE Trademark

Serial Number: 85218796 • Registration: 4145019

METACYTE is a trademark filed by Metacyte Business Lab LLC on January 16, 2011. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Metacyte Business Lab LLC

201 E. Jefferson Street, Suite 125
Louisville, KY 40202

Entity Type: 16

Trademark Details

Filing Date

January 16, 2011

Registration Date

May 22, 2012

Published for Opposition

March 6, 2012

Cancellation Date

December 28, 2018

Goods & Services

Financial services, namely, business fundraising for others; Financial services, namely, raising debt and equity capital for others

Assistance, advisory services and consultancy with regard to business planning, business analysis, business management, and business organization; Business consultation and management regarding marketing activities and launching of new products; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services in the field of Pharmaceuticals, medical devices, medical diagnostics, drug delivery, biotechnology, life and health sciences technologies, drug discovery and bioinformatics; Business consulting, management, planning and supervision; Business development services, namely, providing start-up support for businesses of others; Business management and consultation in the field of Pharmaceuticals, medical devices, medical diagnostics, drug delivery, biotechnology, life and health sciences technologies, drug discovery and bioinformatics; Business management consulting and advisory services for the Pharmaceuticals, medical devices, medical diagnostics, drug delivery, biotechnology, life and health sciences technologies, drug discovery and bioinformatics industry; Business organization and management consulting; Management and business consulting services in the field of Pharmaceuticals, medical devices, medical diagnostics, drug delivery, biotechnology, life and health sciences technologies, drug discovery and bioinformatics; New business venture development and formation consulting services; Providing technical consulting services and information management services, namely, clinical data and regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval

Filing History

CANCELLED SEC. 8 (6-YR)
Dec 28, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 22, 2017 REM1
REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Feb 24, 2016 CORV
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 24, 2016 EWAF
REGISTERED-PRINCIPAL REGISTER
May 22, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 6, 2012 NPUB
PUBLISHED FOR OPPOSITION
Mar 6, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 28, 2012 PREV
ASSIGNED TO LIE
Jan 28, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2012 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 10, 2012 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 10, 2012 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 10, 2012 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 10, 2012 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 25, 2011 GNFN
FINAL REFUSAL E-MAILED
Oct 25, 2011 GNFR
FINAL REFUSAL WRITTEN
Oct 25, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2011 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2011 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2011 CNRT
ASSIGNED TO EXAMINER
Apr 7, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2011 NWOS
NEW APPLICATION ENTERED
Jan 19, 2011 NWAP